Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Item

http://www.wikidata.org/entity/Q33805542

Q33805542

about

Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication Novel perspectives on mucormycosis: pathophysiology, presentation, and management.Cell wall assembly in Saccharomyces cerevisiae Mucormycosis, pseudallescheriasis, and other uncommon mold infections Recent advances in the management of mucormycosis: from bench to bedside Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine Biology, systematics, and clinical manifestations of Zygomycota infections Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses.Carbohydrate-active enzymes from the zygomycete fungus Rhizopus oryzae: a highly specialized approach to carbohydrate degradation depicted at genome level.The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infections Recent advances in the treatment of mucormycosis.Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoter Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.Zygomycosis in Immunocompromised non-Haematological Patients.Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans Human Fungal Pathogens of Mucorales and Entomophthorales.Effective treatment of cerebral mucormycosis associated with brain surgery The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.How I treat mucormycosis.The iron chelator deferasirox protects mice from mucormycosis through iron starvation Combination therapy for mucormycosis: why, what, and how?Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin.The pharmacology and clinical use of caspofungin.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).CNS pharmacokinetics of antifungal agents.Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.Drug combinations against Mucor irregularis in vitro.In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.Locked-in syndrome after basilary artery thrombosis by mucormycosis masquerading as meningoencephalitis in a lymphoma patient.CotH3 mediates fungal invasion of host cells during mucormycosis.Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis Echinocandin pharmacodynamics: review and clinical implications.Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.Epidemiology and treatment of mucormycosis.Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.

P2860

Q21563342-DFFF0D55-EDBF-49AE-A4E5-43DCEEDF14BE Q24530554-02AB45E6-BE11-45CF-8D61-A85A69698CA4 Q24549234-1C21800F-B14D-47A6-B46C-EAA7831A1FD7 Q24603297-A557FFC8-05B5-43D1-A538-2D9DE5AB3BD2 Q24642450-449AE3D4-2688-4943-98F3-0365EAEC5717 Q28547234-721EA03E-51E2-4A0C-B733-CA25698A0FE9 Q28656453-39998905-77F8-4C25-8462-7DCEFF0E0AE2 Q33707593-0D21C217-A7A8-4D6D-9376-F5324BE836DE Q33795209-A348496A-6A66-4291-AB67-8DD88F576688 Q34017347-79D9C05C-0159-4366-BBBC-FE1CF7A816F3 Q34058831-0D334DF2-EF2C-476B-9A14-AA2071AD5195 Q34108585-15F9F2CD-7C99-4327-ACE7-159F399ECFE4 Q34161213-064CD581-546D-43CF-A612-2FE7503340BD Q34315804-F3FAC7F4-98ED-41A9-BEA5-78BFA2180098 Q34596761-0A81E501-B16C-4627-919B-C04E98202286 Q35010681-71A59ED4-1C35-413C-8BB7-3E23DC075C76 Q35065748-AECAC4D4-0DBC-480A-9386-E6D53224CB99 Q35215384-7F5745D3-C465-4965-9A61-DC20253776AB Q35245238-1C199416-6336-4203-AF06-88BA89D1FF19 Q35449392-2487C989-F8CD-45A0-8294-6C478BED4D40 Q35561242-B696FDAE-63CC-434A-B233-2CC20D1BDB91 Q35797637-239029FD-3BC8-46BD-A193-ADB2590E68F3 Q35960985-7D498EBC-351D-4E8B-B768-179A411693A3 Q35974333-75442D69-2059-4067-A2A0-20027FF88071 Q36235415-005833F8-4633-4652-9C24-1BC1AD85B5FD Q36684261-222DBB79-2E10-48F3-90A3-40711A81C1C4 Q36788428-7EA9DF41-E73E-4F6D-AC43-59A410DD9BE9 Q36825717-7CAE1FD9-DB99-428B-B038-BCFEF8303096 Q36862446-D7D9711C-C1DD-4C84-A567-46CE859AD245 Q36909333-C95B0DE3-3D92-4618-8B51-7A997C5DB508 Q36969836-5C767446-10EC-4BB7-AADB-46126CB19BE1 Q36969929-516EC96C-8788-4768-ACD6-F1B31CDDE80C Q37274705-D62CFD64-A032-42EE-AA81-1EF8955895D8 Q37406764-45E3427C-D97E-4648-AFFB-6E9F156731DD Q37410618-EC09B5D0-93CE-42B3-9044-16E8D2D7321A Q37475959-748F0662-51A7-4A59-8E04-5BA8AFBD5390 Q37718385-58EA11B6-767B-4246-B266-26B24A6435F4 Q37785979-5ED7CAD6-57AC-4147-996E-035B2BE151AE Q38135904-87C9DC8A-1A38-4A39-8088-F0D9D6C83B8B Q38245046-8D7433B1-7B2E-4F3D-B042-040565EA3923

P2860

Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Item

http://www.wikidata.org/entity/Q33805542

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu